Enveric Biosciences
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell ENVB and other ETFs, options, and stocks.About ENVB
Enveric Biosciences, Inc. is a biotechnology company which engages in the development of neuroplastogenic small-molecule therapeutics for the treatment of depression, anxiety, addiction, and other psychiatric disorders. The company was founded on February 28, 1994 and is headquartered in Cambridge, MA.
CEOJoseph Tucker
CEOJoseph Tucker
Employees5
Employees5
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded1994
Founded1994
Employees5
Employees5
ENVB Key Statistics
Market cap2.47M
Market cap2.47M
Price-Earnings ratio-0.04
Price-Earnings ratio-0.04
Dividend yield—
Dividend yield—
Average volume109.30K
Average volume109.30K
High today$4.60
High today$4.60
Low today$4.11
Low today$4.11
Open price$4.60
Open price$4.60
Volume78.05K
Volume78.05K
52 Week high$96.30
52 Week high$96.30
52 Week low$4.11
52 Week low$4.11
Stock Snapshot
With a market cap of 2.47M, Enveric Biosciences(ENVB) trades at $4.15. The stock has a price-to-earnings ratio of -0.04.
On 2025-12-28, Enveric Biosciences(ENVB) stock moved within a range of $4.11 to $4.60. With shares now at $4.15, the stock is trading +1.0% above its intraday low and -9.8% below the session's peak.
Trading activity shows a volume of 78.05K, compared to an average daily volume of 109.3K.
The stock's 52-week range extends from a low of $4.11 to a high of $96.30.
The stock's 52-week range extends from a low of $4.11 to a high of $96.30.
People also own
Based on the portfolios of people who own ENVB. This list is generated using Robinhood data, and it’s not a recommendation.